Business

Drugmakers bet billions that targeted radiation could become the next cancer breakthrough

Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind Novartis' Pluvicto.

adminadmin
Sep 16, 2024 - 23:00
 0  5
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
Bristol Myers Squibb, AstraZeneca, Eli Lilly and other drug companies have invested some $10 billion on promising cancer technology behind Novartis' Pluvicto.
Read More

Tags:

Previous Article

Standard vs. itemized: Who deducts what?

Next Article

Stocks making the biggest moves midday: Nuvalent, Alcoa, Sprouts Farmers Market,...

admin
admin

Related Posts

Apple shares drop 5% after Warren Buffett's Berkshire Hathaway slashes stake by half

Apple shares drop 5% after Warren Buffett's Berkshire H...

admin Aug 5, 2024  0  9

China's property market has 'not found a bottom' yet, Standard Chartered CEO Bill Winters says

China's property market has 'not found a bottom' yet, S...

admin Sep 9, 2024  0  14

U.S. crude oil heads to third straight weekly gain as fears grow of Israel-Hezbollah war

U.S. crude oil heads to third straight weekly gain as f...

admin Jun 28, 2024  0  6